Mumbo M, Nyaboga E, Kinyua J, Muge E, Mathenge S, Muriira G
Front Antibiot. 2025; 2():1156258.
PMID: 39816642
PMC: 11731917.
DOI: 10.3389/frabi.2023.1156258.
Belay W, Getachew M, Tegegne B, Teffera Z, Dagne A, Zeleke T
Front Pharmacol. 2024; 15:1444781.
PMID: 39221153
PMC: 11362070.
DOI: 10.3389/fphar.2024.1444781.
Singh G, Rana A, Smriti
Arch Microbiol. 2024; 206(6):280.
PMID: 38805035
DOI: 10.1007/s00203-024-03998-2.
Boccabella L, Palma E, Abenavoli L, Scarlata G, Boni M, Ianiro G
Antibiotics (Basel). 2024; 13(3).
PMID: 38534668
PMC: 10967554.
DOI: 10.3390/antibiotics13030233.
Zafer M, Mohamed G, Ibrahim S, Ghosh S, Bornman C, Elfaky M
Arch Microbiol. 2024; 206(3):101.
PMID: 38353831
PMC: 10867068.
DOI: 10.1007/s00203-023-03826-z.
Limitations in predicting reduced susceptibility to third generation cephalosporins in Escherichia coli based on whole genome sequence data.
Heydecke A, Yin H, Tano E, Sutterlin S
PLoS One. 2023; 18(11):e0295233.
PMID: 38033151
PMC: 10688838.
DOI: 10.1371/journal.pone.0295233.
A Review of the Resistance Mechanisms for -Lactams, Macrolides and Fluoroquinolones among .
Zahari N, Engku Abd Rahman E, Irekeola A, Ahmed N, Rabaan A, Alotaibi J
Medicina (Kaunas). 2023; 59(11).
PMID: 38003976
PMC: 10672801.
DOI: 10.3390/medicina59111927.
An Overview of Preventive Strategies and the Role of Various Organizations in Combating Antimicrobial Resistance.
Shelke Y, Bankar N, Bandre G, Hawale D, Dawande P
Cureus. 2023; 15(9):e44666.
PMID: 37799257
PMC: 10550263.
DOI: 10.7759/cureus.44666.
Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review.
Alfei S, Schito G, Schito A
Pharmaceutics. 2023; 15(7).
PMID: 37514074
PMC: 10384972.
DOI: 10.3390/pharmaceutics15071889.
Collateral sensitivity: An evolutionary trade-off between antibiotic resistance mechanisms, attractive for dealing with drug-resistance crisis.
Yekani M, Azargun R, Sharifi S, Nabizadeh E, Nahand J, Ansari N
Health Sci Rep. 2023; 6(7):e1418.
PMID: 37448730
PMC: 10336338.
DOI: 10.1002/hsr2.1418.
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health.
Salam M, Al-Amin M, Salam M, Pawar J, Akhter N, Rabaan A
Healthcare (Basel). 2023; 11(13).
PMID: 37444780
PMC: 10340576.
DOI: 10.3390/healthcare11131946.
Genetic Factors That Contribute to Antibiotic Resistance through Intrinsic and Acquired Bacterial Genes in Urinary Tract Infections.
Harris M, Fasolino T, Ivankovic D, Davis N, Brownlee N
Microorganisms. 2023; 11(6).
PMID: 37374909
PMC: 10300863.
DOI: 10.3390/microorganisms11061407.
Antimicrobial Resistance: Two-Component Regulatory Systems and Multidrug Efflux Pumps.
De Gaetano G, Lentini G, Fama A, Coppolino F, Beninati C
Antibiotics (Basel). 2023; 12(6).
PMID: 37370284
PMC: 10295115.
DOI: 10.3390/antibiotics12060965.
A three-species synthetic community model whose rapid response to antagonism allows the study of higher-order dynamics and emergent properties in minutes.
Aguilar-Salinas B, Olmedo-Alvarez G
Front Microbiol. 2023; 14:1057883.
PMID: 37333661
PMC: 10272403.
DOI: 10.3389/fmicb.2023.1057883.
Design and Synthesis of Novel Antimicrobial Agents.
Breijyeh Z, Karaman R
Antibiotics (Basel). 2023; 12(3).
PMID: 36978495
PMC: 10045396.
DOI: 10.3390/antibiotics12030628.
Clinical Resistant Strains of and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins.
Lila A, Alharby T, Alanazi J, Alanazi M, Abdallah M, Danish Rizvi S
Antibiotics (Basel). 2023; 12(3).
PMID: 36978327
PMC: 10044631.
DOI: 10.3390/antibiotics12030461.
A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic.
Rehman S
J Infect Public Health. 2023; 16(4):611-617.
PMID: 36857834
PMC: 9942450.
DOI: 10.1016/j.jiph.2023.02.021.
Inducible Mega-Mediated Macrolide Resistance Confers Heteroresistance in Streptococcus pneumoniae.
Lohsen S, Stephens D
Antimicrob Agents Chemother. 2023; 67(3):e0131922.
PMID: 36847556
PMC: 10019249.
DOI: 10.1128/aac.01319-22.
Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.
Jagdmann J, Andersson D, Nicoloff H
PLoS Biol. 2022; 20(9):e3001808.
PMID: 36170241
PMC: 9550176.
DOI: 10.1371/journal.pbio.3001808.
Metal-Based Nanoparticles: Antibacterial Mechanisms and Biomedical Application.
Franco D, Calabrese G, Guglielmino S, Conoci S
Microorganisms. 2022; 10(9).
PMID: 36144380
PMC: 9503339.
DOI: 10.3390/microorganisms10091778.